SCHEMBL6773561

SCHEMBL6773561

COc1ccc(C(=O)Nc2ccc(-c3cc(C4CC4)n(C(=O)O)n3)c(O)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.48
▸ ALDH1A1 P00352 6/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ HPGD P15428 1/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ RAB9A P51151 8/20 0.46
▸ NPC1 O15118 8/20 0.46
▸ TP53 P04637 6/20 0.46
▸ SMN1; SMN2 Q16637 5/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ KCNK9 Q9NPC2 1/20 0.46
▸ ROCK2 O75116 1/20 0.46
▸ NR4A1 P22736 1/20 0.45
▸ MCL1 Q07820 1/20 0.45
▸ CCNA2 P20248 1/20 0.44
▸ CDK2 P24941 1/20 0.44
▸ CCNA1 P78396 1/20 0.44
▸ PKM P14618 2/20 0.44
▸ NFKB1 P19838 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6607134 0.85 MAPT (0.43) MAPTALDH1A1KDM4EHPGDKMT2A
SCHEMBL6619980 0.81 GCGR (0.45) RAB9ANPC1
SCHEMBL6620182 0.81 MAPT (0.47) MAPTALDH1A1KDM4EHPGDKMT2A
SCHEMBL6616145 0.79 CCNA2 (0.66) MAPTALDH1A1KDM4EHPGDKMT2A
SCHEMBL6615885 0.78 NPC1 (0.47) MAPTALDH1A1KDM4EHPGDKMT2A
SCHEMBL6615580 0.78 RAB9A (0.52) MAPTALDH1A1KDM4EHPGDKMT2A
SCHEMBL6617816 0.77 KMT2A (0.52) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL6618133 0.76 RAB9A (0.41) MAPTKDM4EKMT2AMEN1RAB9A
SCHEMBL6618182 0.76 MEN1 (0.43) MAPTKMT2AMEN1RAB9ANPC1
SCHEMBL6618517 0.76 KDM4E (0.45) MAPTALDH1A1KDM4EHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040010027-A1 Hydroxphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical comositions comprising them PHARMACIA & UPJOHN SPA (IT) 2004-01-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040010027-A1 Hydroxphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical comositions comprising them CNKSR1, CSNK1A1, CDK6 MAPT 3418/4885ALDH1A1 3793/4885KDM4E 1717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback